Improvement of Hemolysis in Muscle Phosphofructokinase Deficiency by Restriction of Exercise

Internal Medicine

Volumn 35, Issue 3, 1996, Pages 222-226

  Toyoda, Hideki ^a   Nakase, Tsutomu ^b   Tomeoku, Makoto ^b   Morita, Koichi ^b   Kato, Masami ^b   Murata, Tetsuya ^b   Ono, Akira ^c   Kuwajima, Masamichi ^c   Kono, Norio ^c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b SUZUKA GENERAL HOSPITAL   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Erythrocyte; Glycogenosis type VII

Indexed keywords

6 PHOSPHOFRUCTOKINASE; BILIRUBIN; CREATINE KINASE; GLYCOGEN;

ADULT; ARTICLE; BIOPSY; BLOOD; CASE REPORT; ENZYMOLOGY; ERYTHROCYTE; EXERCISE; EXERCISE TEST; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 7; HEMOLYSIS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; ULTRASTRUCTURE;

ADULT; BILIRUBIN; BIOPSY; CREATINE KINASE; ERYTHROCYTES; EXERCISE; EXERCISE TEST; FEMALE; GLYCOGEN; GLYCOGEN STORAGE DISEASE TYPE VII; HEMOLYSIS; HUMANS; MUSCLE, SKELETAL; PHOSPHOFRUCTOKINASE-1;

EID: 0030095794     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.222     Document Type: Article

References (27)

1. Tarui S, Okuno G, Ikura Y, Tanaka T, Suda M, Nishikawa M. Phosphofructokinase deficiency in skeletal muscle. Biochem Biophys Res Commun 19: 517, 1965.
2. Kono N, Mineo I, Sumi S, Shimizu T, Kang J, Nonaka K, Tarui S. Metabolic basis of improved exercise tolerance; muscle phosphorylase deficiency after glucagon administration. Neurology (Cleveland) 34: 1471, 1984.
3. Mineo I, Kono N, Hara N, et al. Myogenic hyperuricemia. N Engl J Med 317: 75, 1987.
4. Kono N, Kuwajima M, Tarui S. Alternation of glycolytic intermediary metabolism in erythrocytes during diabetic ketoacidosis and its recovery phase. Diabetes 30: 346, 1981.
5. Chapman RG, Hennessey MA, Waltersdorph AM, Huennekens FM, Gabrio BW. Erythrocyte metabolism. V. levels of glycolytic enzymes and regulation of glycolysis. J Clin Invest 41: 1249, 1962.
6. Nortmann EA. Isolation of crystalline phosphoglucose isomerase from rabbit muscle. J Biol Chem 239: 1545, 1964.
7. Bucher T, Pfleiderer G. Pyruvate Kinase from Muscle, in: Methods in Enzymology, Colowich SP, Kaplan NO Eds. Academic Press Ine, New York, Methods in Enzymology, 1995, p.435.
8. Bergmeyer HU, Gawehn K, Grassl M. Enzymes as Biochemical Reagents. in: Methods of Enzymatic Analysis, Vol. 1. Bergmeyer HU, Ed. Academic Press Inc, New York and London, 1974, p.423.
9. Tarui S, Kono N, Ueda K. Purification and properties of rabbit erythrocyte phosphofructokinase. J Biol Chem 247: 1138, 1972.
10. Layzer RB, Rowland LP, Ranny HM. Muscle phosphofructokinase deficiency. Arch Neurol 17: 512, 1967.
11. Kahn A, Etiemble J, Meienhofer MC, Bovin P. Erythrocyte phosphofructokinase deficiency associated with an unstable variant of muscle phosphofructokinase. Clinica Chem Acta 61: 415, 1975.
12. Kono N, Mineo I, Shimizu T, et al. Increased plasma uric acid after exercise in muscle phosphofructokinase deficiency. Neurology 36: 106, 1986.
13. Shimizu T, Kono N, Kiyokawa H, et al. Erythrocyte glycolysis and its marked alternation by muscular exercise in type VII glycogenosis. Blood 71: 1130, 1988.
14. Hamaguchi T, Nakajima H, Noguchi T, Ono A, Kono N, Tarui S, Kuwajima M, Matsuzawa Y. A new variant of muscle phosphofructokinase deficiency in a Japanese case with abnormal RNA splicing. Biochem Biophys Res Commun 202: 444, 1994.
15. Nakajima H, Noguchi T, Yamasaki T, Kono N, Tanaka T, Tarui S. Cloning of human muscle phosphofructokinase cDNA. FEBS Lett 223: 113, 1987.
16. Lee CP, Kao MC, French BA, Putney FC, Chang SH. The rabbit muscle phosphofructokinase gene. J Biol Chem 262: 4195, 1987.
17. Poorman RA, Randolph A, Kemp RG, Heinrikson RL. Evolution of phosphofructokinase-gene duplication and creation of new effector sites. Nature 309: 467, 1984.
18. Etiemble J, Kahn A, Boivin J, Bernard JF, Goudemand M. Hereditary hemolytic anemia with erythrocyte phosphofructokinase deficiency. Hum Genet 31: 83, 1976.
19. Murakami J. Changes of erythrocyte deformability induced by calcium accumulation and calmodulin inhibitors. J Physiol Soc Jpn 49: 119, 1987.
20. Murphy JR. The influence of pH and temperature on some physical properties of normal erythrocytes and erythrocytes from patient with hereditary spherocytosis. J Lab Clin Med 69: 758, 1967.
21. Tarui S, Kono N, Kuwajima M, Kitani T. Hereditary and acquired abnormalities on erythrocyte phosphofructokinase activity. Hemoglobin 4: 581, 1980.
22. Joshua H, Vries AD. Effect of exercise on red blood cell in march hemoglobinuria. Am J Clin Pathol 46: 341, 1966.
23. Shiraki K. The effect of splenectomy on sports anemia. J Physiol Soc Jpn 30: 1, 1968.
24. Rongausch H. Influence of shape stabilizing agents on the deformability and morphology of lysolecitin-treated erythrocytes. Arzneim-Forsch/ Drug Res 38: 1478, 1988.
25. Shimizu T, Kuwajima M, Kono N, et al. Kinetic properties of mutant enzymes in erythrocyte phosphofructokinase deficiency and erythrocyte pyruvate kinase deficiency. Med J Osaka Univ 33: 49, 1983.
26. Waterbury L, Frenkel FP. Hereditary nonspherocytic hemolysis with erythrocyte phosphofructokinase deficiency. Blood 39: 415, 1972.
27. Tani K, Fujii H, Takegawa S, et al. Two cases of phosphofructokinase deficiency associated with congenital hemolytic anemia found in Japan. Am J Hematol 14: 165, 1983.